二维剪切波弹性成像变化预测乙肝相关肝癌消融后进展
本研究纳入161例初治乙肝相关肝细胞癌患者,分为训练组107例与验证组54例,收集消融前及消融后1个月二维剪切波弹性成像Emean等指标。中位随访12个月,36例出现肿瘤进展。结果显示消融前PT较长、消融后1个月AFP较高及Emean下降与消融后无进展生存期缩短相关。
要点
- 消融后1个月Emean较术前下降者无进展生存期更短,报告时应提示随访风险。
- 消融前PT延长与消融后1个月AFP升高也是无进展生存期的独立预测因素。
- 消融后Emean变化可分为下降、无显著变化与升高,升高者进展风险相对较低。
核心结论
- 消融前PT较长、消融后1个月AFP较高及消融后1个月Emean下降与乙肝相关肝细胞癌消融后无进展生存期缩短相关。
- 二维剪切波弹性成像测量值变化可能作为肝细胞癌消融后进展的潜在预测指标。
研究设计与样本
- 回顾性研究,共纳入161例初治慢性乙肝相关肝细胞癌患者,分为训练组107例与验证组54例。
- 收集消融前、消融后1个月及其他计划随访节点的二维剪切波弹性成像Emean数据。
- 采用Cox回归分析无进展生存期的独立预测因素,并建立预测模型。
关键影像表现/征象
- 与消融前相比,消融后1个月Emean在40例患者中下降,在71例患者中升高,在50例患者中无显著变化。
诊断标准与关键数值
- 消融前凝血酶原时间为无进展生存期独立预测因素,p=0.014,HR=1.54。
- 消融后1个月甲胎蛋白为无进展生存期独立预测因素,p=0.014,HR=1.01。
- 以Emean下降为参照,无显著变化p=0.096,HR=0.38;Emean升高p=0.014,HR=0.22。
- Cox模型在训练组p<0.001,HR=2.10,在验证组p=0.009,HR=1.17。
临床应用与阅片要点
- 消融后短期二维剪切波弹性成像测量值变化方向具有预后意义,可纳入消融后影像随访评估。
- 阅片时应关注消融后1个月肝背景硬度与消融前比较的变化趋势,而非仅记录绝对值。
局限性
- 原文未报告样本量较小、单中心或回顾性研究设计等相关局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Ablation is an important therapy for hepatocellular carcinoma (HCC). This study aims to explore the changes in pre- and short-term-post-ablative two-dimensional shear wave elastography (2D-SWE) measurements and assess the feasibility of using pre- and short-term-post-ablative indicators, including 2D-SWE measurements, to predict HCC progression after curative ablation.
METHODS: A total of 161 treatment-naïve chronic hepatitis B-related HCC patients were divided into training (n = 107) and validation (n = 54) groups. Data, including 2D-SWE measurements (Emean), were collected pre-ablation, 1 mo post-ablation, and at other scheduled follow-ups. The independent predictor of progression-free survival (PFS) was analyzed using Cox regression analysis, and a prediction model was established.
RESULTS: The median follow-up time was 12 mo (range 1-36 mo), and tumor progression occurred in 36 (22.4%) patients. Compared to the pre-ablation, the 1-mo-post-ablative Emean decreased in 40 (24.8%) patients, while increased in 71 (44.1%) patients, and did not significantly change in 50 (31.1%) patients. Cox analysis identified pre-ablative prothrombin time (PT; p = 0.014, HR = 1.54), 1-mo-post-ablative alpha-fetoprotein (AFP; p = 0.014, HR = 1.01), and categorized Emean change between pre-ablative and 1-mo-post-ablative period (with decrease as reference, not-significant-change: p = 0.096, HR = 0.38; increase: p = 0.014, HR = 0.22) as the independent predictor of PFS. The Cox model could significantly predict PFS in both training (p < 0.001, HR = 2.10) and validation (p = 0.009, HR = 1.17) groups.
CONCLUSION: Longer pre-ablation PT, higher 1-mo post-ablation AFP, and decreased 1-mo post-ablation Emean were associated with shorter post-ablation PFS. Changes in 2D-SWE measurements may serve as a potential indicator of HCC progression after ablation.
引用
- Huang, Lin, Zhong, et al. Change in Two-Dimensional Shear Wave Elastography: A New Predictor of Hepatitis B-Related HCC Progression After Ablation. Ultrasound Med Biol. 2026. PMID: 42420054. doi:10.1016/j.ultrasmedbio.2026.06.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。